Hims & Hers Health (HIMS) Deferred Taxes (2021 - 2026)
Hims & Hers Health (HIMS) posted Deferred Taxes of -$14.0 million for Q1 2026, down 301.93% sequentially from -$3.5 million in Q4 2025, and down 1470.22% YoY from $1.0 million in Q1 2025.
Hims & Hers Health (HIMS) Deferred Taxes (2021 - 2026) Analysis & Trends
Hims & Hers Health has reported Deferred Taxes for 6 years, with the latest figure at -$14.0 million in Q1 2026.
- Quarterly Deferred Taxes fell 1470.22% year-over-year to -$14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.0 million (up 58.35% YoY) and the FY2025 annual result came in at -$13.0 million, up 78.98% from the prior year.
- Deferred Taxes fell to -$14.0 million in Q1 2026 per HIMS's latest filing, from -$3.5 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $862000.0 in Q3 2025 and troughed at -$54.3 million in Q3 2024.
- A 5-year average of -$5.2 million and a median of -$122000.0 in 2022 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes soared 143.75% in 2023, then slumped 945700.0% in 2025.
- Over 5 years, Deferred Taxes stood at -$214000.0 in 2022, then soared by 107.94% to $17000.0 in 2023, then plunged by 43094.12% to -$7.3 million in 2024, then soared by 52.43% to -$3.5 million in 2025, then plunged by 301.93% to -$14.0 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$14.0 million, -$3.5 million, and $862000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | -9.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.36 Mn |
| Mar 31, 2026 | -13.98 Mn |
| Dec 31, 2025 | -3.48 Mn |
| Sep 30, 2025 | 862,000.00 |
| Jun 30, 2025 | -9.46 Mn |
| Mar 31, 2025 | -890,000.00 |
| Dec 31, 2024 | -7.31 Mn |
| Sep 30, 2024 | -54.34 Mn |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -69,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Dec 31, 2022 | -214,000.00 |
| Sep 30, 2022 | -122,000.00 |
| Jun 30, 2022 | -146,000.00 |
| Mar 31, 2022 | -112,000.00 |
| Dec 31, 2021 | -210,000.00 |
| Sep 30, 2021 | -3.18 Mn |